Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets open in 6 hours 35 minutes
ALL ORDS
8,076.70
+11.20
(+0.14%)
AUD/USD
0.6576
-0.0024
(-0.37%)
ASX 200
7,804.50
+11.20
(+0.14%)
OIL
78.75
+0.37
(+0.47%)
GOLD
2,323.20
-1.00
(-0.04%)
Bitcoin AUD
94,966.47
-1,560.31
(-1.62%)
Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.01
-0.20
(-0.94%)
At close: 03:04PM CST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,180,715
3,477,439
3,157,402
3,652,095
2,261,177
Cost of revenue
504,199
537,674
499,947
986,428
226,306
Gross profit
2,676,516
2,939,764
2,657,454
2,665,667
2,034,871
Operating expenses
Research development
523,892
500,749
801,857
354,264
267,061
Selling general and administrative
1,216,756
1,294,338
1,144,558
643,747
913,835
Total operating expenses
1,708,369
1,795,280
2,020,824
1,071,936
1,291,369
Operating income or loss
968,147
1,144,484
636,630
1,593,731
743,502
Interest expense
119,008
113,713
108,972
54,512
2,338
Income before tax
763,661
940,320
-338,246
1,439,245
772,410
Income tax expense
53,791
79,016
-205,539
175,868
93,224
Income from continuing operations
709,870
861,304
-132,708
1,263,377
679,186
Net income
709,907
861,304
-132,708
1,263,377
679,186
Net income available to common shareholders
709,907
861,304
-132,708
1,263,377
679,186
Basic EPS
0.26
0.77
-0.12
1.85
0.64
Diluted EPS
0.26
0.77
-0.12
1.82
0.63
Basic average shares
1,316,993
1,118,576
1,105,899
682,907
1,055,047
Diluted average shares
1,316,993
1,118,576
1,105,899
694,163
1,075,939
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.